# The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHD

> **NCT02267200** · — · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 30 (actual)

## Conditions studied

- Hypertension,Pulmonary

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02267200
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02267200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02267200, "The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02267200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*